期刊文献+

鬼臼毒素MPEG修饰脂质体的制备及体外释放的研究

Preparation and in Vitro Release of MPEG-modified Liposomes Containing Podophyllotoxin
下载PDF
导出
摘要 目的:制备鬼臼毒素(PPT)MPEG修饰脂质体(PPT-MPL),以及考察PPT-MPL体外释放行为。方法:合成甲氧基聚乙二醇磷脂酰乙醇胺(MPEG-PE),并用薄膜分散法制备脂质体;以包封率为指标,运用正交试验法设计优化脂质体处方和工艺,采用改进的超滤法测定脂质体的包封率,以及透析法研究体外释放行为。结果:优化后的PPT-MPL平均粒径为(106.20±4.10)nm,包封率为(83.30±2.50)%;加入血浆后PPT-MPL体外释放速率比普通脂质体慢(P<0.05)。结论:该法制备PPT-MPEG修饰脂质体,具有粒径小、包封率高以及明显的缓释效果。 Objective: To prepare MPEG-modified liposomes containing podophyllotoxin (PPT-MPL) and to study their in vitro release behavior. Methods: Methoxy-poly(ethylene glycol)-phosphatidylethanolamine (MPEG-PE) was synthesized by two-step process and used as a drug carrier material. PPT-MPL was prepared by thin-film dispersion method. The preparation was optimized by orthogonal design. An improved ultrafiltration method was used to determi- nate liposome entrapment efficiency. In vitro drug release behavior was studied by dialysis method. Results: The aver- age diameter and entrapment efficiency of the optimized liposomes were (106.20±4.10)nm and (83.30±2.50)%, respectively. In presence of plasma podophyllotoxin released more slowly in vitro from the MPEG-modified liposomes than the common liposomes(P〈0.05).Conclusion: The optimized liposomes have smaller size, higher entrapment efficiency and more sustained release behavior.
作者 王娟 栾立标
出处 《抗感染药学》 2012年第3期186-189,共4页 Anti-infection Pharmacy
关键词 鬼臼毒素 MPEG修饰脂质体 正交设计 体外释放 podophyllotoxin MPEG-modified liposomes orthogonal design in vitro release
  • 相关文献

参考文献9

二级参考文献39

  • 1潘弘,王恬力,陆伟跃.chTNT-3-空间稳定脂质体的制备及理化性质考察[J].中国医药工业杂志,2006,37(5):318-322. 被引量:3
  • 2蒋福升,丁志山,吕圭源.聚乙二醇前药的研究进展[J].中国药学杂志,2007,42(12):881-885. 被引量:13
  • 3国家药典委员会.中国药典[M].北京:化学工业出版社,2000.87.
  • 4Zhang JA, Xuan T, Parmar M, et al. Development and characterization of a novel liposome-based formulation of SN-38 [J]. IntdPharm, 2004, 270 (1-2) : 93-107.
  • 5Sapra P, Zhao H, Mehlig M, et al. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin- 11-refractory model [J]. Clin Cancer Res, 2008, 14(6) : 1888-1896.
  • 6Zhang J, Fan XD, Liu YF, et al. Synthesis of poly (ethylene glycol)-metaxalone conjugates and study of its controlled release in vitro [J]. IntJPharm, 2007, 332 (1-2): 125-131.
  • 7Greenwald RB, Choe YH, McGuire J, et al. Effective drug delivery by PEGylated drug conjugates [J]. Adv Drug Deliv Rev, 2003, 55 (2) : 217-250.
  • 8Hans M, Shimoni K, Danino D, et al. Synthesis and characterization of mPEG-PLA prodrug micelles [J]. Biomacromolecules, 2005, 6 (5): 2708-2717.
  • 9Greenwald RB, Choe YH, Wu D. Selective phenolic acylation of 10-hydroxycamptothecin using poly(ethylene glycol) carboxylic acid [J]. Bioorg Med Chem Lett, 2003, 13 (3) : 577-580.
  • 10Greenwald RB, Gilbert CW, Pendri A, et al. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness [J]. J Med Chem, 1996, 39 (2) : 424-431.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部